Drug Trial Radar · NCT00224055
Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
Last checked: Nov 20, 2026Latest source record: Mar 29, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
89
Actual
Start
Apr 2003
Primary completion
Sep 2004
Study completion Sep 2004
Sponsor
- Lead sponsor
- Watson PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Sep 22, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate (a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease patients who are not receiving erythropoietic agents (hormones that stimulate the bone marrow to make more red blood cells).
Conditions
- Anemia, Iron-Deficiency
- Kidney Failure, Chronic
Interventions
Sodium Ferric Gluconate Complex in Sucrose InjectionDrug
Sodium Ferric Gluconate Complex in Sucrose Injection (Ferrlecit®), 250 mg IV weekly for 4 weeks
Ferrous sulfate tabletsDrug
ferrous sulfate, 325 mg oral, three times daily for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Hemoglobin (Hgb)Time frame: Baseline to 10 weeks
Locations
24 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Tucson, Arizona
Site not named
Los Angeles, California
Site not named
Palo Alto, California
Site not named
San Diego, California
Site not named
Hines, Illinois
Site not named
Indianapolis, Indiana
Site not named
Shreveport, Louisiana
Site not named
Baltimore, Maryland
Site not named
Springfield, Massachusetts
Site not named
Detroit, Michigan
Site not named
St Louis, Missouri
Site not named
Birmingham, New York
Site not named
Mineola, New York
Site not named
New York, New York
Site not named
The Bronx, New York
Site not named
Chapel Hill, North Carolina
Site not named
Cleveland, Ohio
Site not named
Philadelphia, Pennsylvania
Site not named
Charlotte, South Carolina
Site not named
Chattanooga, Tennessee
Site not named
Memphis, Tennessee
Site not named
Houston, Texas
Site not named
Fairfax, Virginia
Site not named
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.